Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave

BACKGROUND: During the COVID pandemic, there was a paucity of data to support clinical decision-making for anticancer treatments. We evaluated the safety of radical treatments which were delivered whilst mitigating the risks of concurrent COVID-19 infection. METHODS: Using descriptive statistics, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Beth, Moss, Charlotte, Monroy-Iglesias, Maria, Roberts, Graham, Dickinson, Harvey, Haire, Kate, Innes, Kathryn, Mulji-Shah, Bansi, Castell, Fiona, Al-Salihi, Omar, Lei, Mary, Francis, Angela, Dann, Bill, Jogia, Vikash, Hamid, Hisham, Challacombe, Ben, Simo, Ricard, Fraser, Stephanie, Gousis, Charalampos, Sawyer, Elinor, Tsotra, Eirini, Roca, Jose, Khan, Muhammad, Josephs, Debra, Enting, Deborah, Van Hemelrijck, Mieke, Harris, Victoria, Dolly, Saoirse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284490/
https://www.ncbi.nlm.nih.gov/pubmed/35840733
http://dx.doi.org/10.1038/s41416-022-01909-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284490/
https://www.ncbi.nlm.nih.gov/pubmed/35840733
http://dx.doi.org/10.1038/s41416-022-01909-0

Ejemplares similares